BÁO CÁO Y HỌC: " PREDICTORS OF DISEASE PROGRESSION IN HIV INFECTION: A REVIEW" PPT

Int. J. Med. Sci. 2006, 3 63International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):63-68 ©2006 Ivyspring International Publisher. All rights reserved Review A Practical Approach to Managing Patients with HCV Infection Richard H. Huang, and Ke-Qin Hu Division of Gast[r]

Int. J. Med. Sci. 2006, 3 47International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):47-52 ©2006 Ivyspring International Publisher. All rights reserved Review The Natural History of Hepatitis C Virus (HCV) Infection Stephen L. Chen 1 2 and Timothy R. Morgan 1 2 1. Gastroente[r]

what appears to be a relatively weak, ineffective immune response since it is inadequate to clear the virus. Since immunologic mediated inflammation is thought to be the mechanism of progressive fibrosis, it is surprising that immune suppression does not ameliorate the disease at the expense[r]

Int. J. Med. Sci. 2006, 3 53International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):53-56 ©2006 Ivyspring International Publisher. All rights reserved Review Hepatitis C Virus (HCV) Infection and Hepatic Steatosis Eugene J. Yoon, and Ke-Qin Hu Division of Gastroenterology a[r]

Int. J. Med. Sci. 2006, 3 79International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):79-83 ©2006 Ivyspring International Publisher. All rights reserved Review Management of HCV Infection and Liver Transplantation Thomas D. Schiano, and Paul Martin Adult Liver Transplantation[r]

Int. J. Med. Sci. 2006, 3 79International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):79-83 ©2006 Ivyspring International Publisher. All rights reserved Review Management of HCV Infection and Liver Transplantation Thomas D. Schiano, and Paul Martin Adult Liver Transplantation[r]

24, the likelihood of an SVR is virtually nil and treatment can be stopped or continued with the only aim to slow liver disease progression in patients with a severe prognosis, without any hope to eradicate infection (Figure 1A) [18, 22]. Ongoing trials are studying whether a pr[r]

(PR) weight based dosing (WBD). In: 40th Annual meeting of the European Association for the Study of Liver Disease; April 13-17, 2005; Paris, France. Int. J. Med. Sci. 2006, 3 7812. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, Detre K, Hoofnagle J. Predictors of patient and gr[r]

Murray-Lyon IM. Prevalence of hepatitis B, C and D virus markers in Yemeni patients with chronic liver disease. J Med Virol 1993;40:330–333. 35. Frommel D, Tekle-Haimanot R, Berhe N, Aussel L, Verdier M, Preux PM, Denis F. A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med[r]

(PR) weight based dosing (WBD). In: 40th Annual meeting of the European Association for the Study of Liver Disease; April 13-17, 2005; Paris, France. Int. J. Med. Sci. 2006, 3 7812. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, Detre K, Hoofnagle J. Predictors of patient and gr[r]

CagA protein. Science 2002; 295: 683-6. 5. Higashi H, Nakaya A, Tsutsumi R, et al. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem 2004; 279: 17205-16. 6. Hatakeyama M. Helicobacter pylori CagA--a potential b[r]

which was established to characterize cognition among individuals initiating HAART for the first time as the country rapidly escalated access to antiretrovi-ral drugs. 2. METHODS Subjects and Clinical Data. We established a longitudinal neuroAIDS cohort within the Southeast Asia Research Coll[r]

the RM group (χ2=1.60, p=0.21). The genotypes of TNF-A T-1031C had no associations with the eradication rate. But among the RM group, the odd ratio (OR) of the TNF-A CT for the eradication rate relative to TT was marginally reduced (OR=0.05, 95% confidence interval, 0.002-1.19). Conclu[r]

C. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 1993;17:20-29. 33. Koike K, Kobayashi M, Gondo M, Hayashi I, Osuga T, Takada S. Hepatitis B virus DNA is frequently found in live[r]

Canada and 9149 subjects were included (4266 men and 4883 women). A high BMI was found to be a significant predictor of asthma incidence in women but not in men. The authors speculate that female sex hormones may play an important role in the aetiology of asthma and that these hormones[r]

Int. J. Med. Sci. 2006, 3 117International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(4):117-123 ©2006 Ivyspring International Publisher. All rights reserved Review PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers? Jos[r]

among natural weight loss supplements. Theoretically, they may promote weight loss by interfering with the breakdown of complex carbohydrates thereby reducing, or at least slowing, the digestive availability of carbo-hydrate-derived calories and/or by providing resistant starches to the lower gastro[r]

Int. J. Med. Sci. 2006, 3 29International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):29-34 ©2006 Ivyspring International Publisher. All rights reserved Review Molecular Virology of Hepatitis C Virus (HCV): 2006 Update Volker Brass1, Darius Moradpour2 and Hubert E. Blum1 1. D[r]

but Cys-C of ≥1.0mg/L; Group III (abnormal), serum Cr of ≥1.3mg/dL. All patients belonging to Group III showed serum levels of Cys-C of 1.0mg/mL or more. Each bar represents the mean ± SD. *P<0.05, significantly different from Group I. 4. Discussion Digoxin shows a narrow therapeutic[r]

highly significant association between the rare C allele and lower plasma HDL concentrations in female subjects. The effect remained significant after correcting for multiparametric testing according to Bonferoni and was seen only in subjects with a BMI below the median. In addition, the non-[r]